Your browser doesn't support javascript.
loading
Changing from NAFLD to MASLD: Similar prognosis of unresectable extrahepatic gastrointestinal cancer under chemotherapy between NAFLD and MASLD.
Suzuki, Hiroyuki; Tanaka, Toshimitsu; Yamaguchi, Shotaro; Miwa, Keisuke; Kawaguchi, Takumi.
Afiliação
  • Suzuki H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Tanaka T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan; Multidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume, Japan. Electronic address: tanaka_toshimitsu@med.kurume-u.ac.jp.
  • Yamaguchi S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan; Multidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume, Japan.
  • Miwa K; Multidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume, Japan.
  • Kawaguchi T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
J Hepatol ; 80(4): e150-e151, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38110007

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica / Neoplasias Gastrointestinais Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica / Neoplasias Gastrointestinais Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article